arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

download Export Data

Incannex Healthcare Inc.

IXHL

$3.12 ▲ +0.04 (+1.30%) at close

17 Visible periods

23 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Incannex Healthcare Inc. shows weak fundamentals, weighed down by Return on Invested Capital and FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $38.5M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -4.3% ↗

FCF / Share $-0.20 ↘

Trailing P/E —

Price / Book 0.6x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

17-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↓ -100.0% —

Net Income Profit after all expenses

$-6.41M

↓ -61.5% —

FCF / Share Free cash flow per share

$-0.20

↓ -1405.6% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -140.4% is weak on an absolute basis (target > 10%)
FCF / Net IncomeFCF / Net Income of 0.27x is weak on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q4 FY2021 Jun 30, 2021 20-F ↗	Q4 FY2020 Jun 30, 2020 20-F ↗
EPS Growth YoY (%)	-75.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	93.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	93.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	47.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-262.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-0.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-72.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-61.5% Weak ↑ Weak Improving Year-over-year change in net income	-8.7% Weak ↑ Weak Improving Year-over-year change in net income	-18.2% Weak ↑ Weak Improving Year-over-year change in net income	-389.1% Weak ↑ Weak Improving Year-over-year change in net income	34.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-711.8% Weak ↓ Weak Declining Year-over-year change in net income	-646.6% Weak ↓ Weak Declining Year-over-year change in net income	-54.8% Weak ↓ Weak Declining Year-over-year change in net income	-68.9% Weak Weak Year-over-year change in net income	75.1% Excellent Excellent Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	—	—	76.2% Excellent Excellent Year-over-year change in free cash flow	—	—	—	67.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q4 FY2021 Jun 30, 2021 20-F ↗	Q4 FY2020 Jun 30, 2020 20-F ↗
FCF / Net Income (x)	0.38x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.43x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.05x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.40x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	8.22x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q4 FY2021 Jun 30, 2021 20-F ↗	Q4 FY2020 Jun 30, 2020 20-F ↗
Return on Invested Capital (%)	-4.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-44.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-53.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-118.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-74.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-68.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-41.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-10.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-5.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-36.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-30.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-45.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-39.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-57.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-43.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-35.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-17.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	-8.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-157%)	-8.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-158%)	-8.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-155%)	-236.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1674%)	-53.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-457%)	—	-82.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-648%)	-57.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-484%)	-42.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-384%)	-3.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-126%)	-3.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	-20.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-234%)	-14.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-196%)	-10.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	—	—	—

⚖️ Is the balance sheet risky? 3 metrics

Metric	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q4 FY2021 Jun 30, 2021 20-F ↗	Q4 FY2020 Jun 30, 2020 20-F ↗
Debt to Equity (x)	—	—	—	—	0.19x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-69%)	3.90x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+551%)	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-74.45M	$-68.90M	$-73.28M	$-15.04M	$-5.31M	$1.67M	$-3.63M	$-5.86M	$-9.30M	$-14.55M	—	$-22.12M	—	—	—	—	—
Debt / EBITDA (x)	—	—	—	—	-0.28x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.78x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q4 FY2021 Jun 30, 2021 20-F ↗	Q4 FY2020 Jun 30, 2020 20-F ↗
Revenue per Share (USD)	—	—	—	—	$0.00	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.35	$-0.02	$-0.02	$24.04	$-0.20	$-0.33	$-0.29	$-0.39	$-0.38	$-0.33	$-0.08	$-0.39	$-0.22	$0.05	—	—	—
Free Cash Flow per Share (USD)	$-0.20	$-0.01	$-0.03	—	—	—	$-0.12	—	—	—	$-0.38	—	$-0.17	—	—	—	—
Book Value per Share (USD)	$5.50	$0.20	$0.22	$0.07	$0.42	$0.05	$0.37	$0.64	$1.09	$1.46	$1.25	$1.31	$1.55	$1.81	—	—	—
Tangible Book Value per Share (USD)	$5.50	$0.20	$0.22	$0.07	$0.42	$0.05	$0.37	$0.64	$1.09	$1.46	$1.25	$1.31	$1.55	$1.81	—	—	—
Basic Weighted Avg Shares (shares)	12.35M	349.46M	310.31M	—	19.63M	17.62M	17.64M	—	15.87M	15.87M	15.87M	—	15.87M	15.40M	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q4 FY2021 Jun 30, 2021 20-F ↗	Q4 FY2020 Jun 30, 2020 20-F ↗
Working Capital (USD)	$78.17M	$73.13M	$76.65M	$12.98M	$8.26M	$4.66M	$5.98M	$10.58M	$13.46M	$18.15M	—	$20.45M	—	—	—	—	—
LT Debt (USD)	—	—	—	—	—	$2.38M	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$75.23M	$73.41M	$77.01M	$13.39M	$7.40M	$965.00K	$6.59M	$11.22M	$14.14M	$18.87M	$19.79M	$20.82M	$24.67M	$27.91M	$24.71M	—	—

📋 What is driving earnings? 4 metrics

Metric	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q4 FY2021 Jun 30, 2021 20-F ↗	Q4 FY2020 Jun 30, 2020 20-F ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	$0.00	$12.00K	$74.00K	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$100.00K	$-65.90M	$66.00M	$143.00B	—	$200.00K	$66.18M	$103.00B	—	—	$12.05M	—	—	—	—	—	—
Net Income, GAAP (USD)	$-6.41M	$-6.41M	$-6.41M	$-31.60M	$-3.97M	$-5.89M	$-5.42M	$-6.46M	$-6.03M	$-726.00K	$-726.00K	$-4.17M	$-3.57M	$-2.92M	—	—	—
Operating Cash Flow (USD)	$-2.46M	$-4.62M	$-9.16M	$-1.48M	—	—	$-2.19M	$-3.64M	—	—	$-5.75M	$-2.58M	$-2.73M	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 17 quarters

Incannex Healthcare Inc.

Analytical Summary

17-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare IXHL with peers